Queensland's health minister, Tim Nicholls, announced the pause on puberty blockers and hormone treatments for new adolescents with gender dysphoria will last until at least 2031. This extension follows the consideration of a review by Prof Ruth Vine, Victoria's former chief psychiatrist. The review highlighted that treatment decisions "must be informed by each individual’s presentation and circumstances" and said, with oversight, "there can be benefit for a young person in being able to access puberty blockers." In 2023, Queensland’s supreme court ruled the first ban illegal, but Nicholls issued a new order hours later to reinstate it. Young people already in treatment continue unaffected. Nicholls said the ban stays until a UK National Health Service clinical trial finishes in 2031. He added, "Some people will disagree with it, but the government’s considered view based on the material it has been provided … is that it is in the public interest that the pause continue while that trial is underway." The Vine review noted that evidence supporting puberty blockers and gender-affirming hormones is limited and low quality but emphasized that limited evidence does not equal evidence of harm. It found some short- and medium-term benefits, including reduced gender-related distress and positive psychosocial impacts. Rachel Hinds, CEO of Open Doors Youth Service, criticized the announcement’s timing, saying, "This really puts the lives of trans and gender-diverse young people at risk," especially as many support services close over the holidays.